Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2012

01-02-2012

Phenotypic Heterogeneity in a Family with a CD40 Ligand Intracellular Domain Mutation

Authors: S. Kiani-Alikhan, P. F. K. Yong, K. C. Gilmour, D. Grosse-Kreul, E. G. Davies, M. A. A. Ibrahim

Published in: Journal of Clinical Immunology | Issue 1/2012

Login to get access

Abstract

We describe a family with the rare mutation R11X that leads to a truncated CD40 ligand (CD40L) missing the intracellular domain. The index case had detectable CD40L expression and presented at the age of 41 years with cerebral toxoplasmosis. A brother and two nephews were also identified as having the same mutation but exhibited milder and variable phenotypes. The older affected nephew had a moderately depressed immunoglobulin G level and a history of pneumonia at 4 months of age. The younger nephew suffered from sinusitis with normal immunoglobulin levels. Both nephews had absent antibody responses to a protein antigen with conserved responses to polysaccharide antigens. The two sisters of the index case are carriers who had elevated levels of IgM but remain well. This mutation may affect CD40 ligand function by reducing cell surface levels, diminishing CD40 interaction or disrupting CD40L intracellular signalling in T cells. The variable phenotype in members of this family offers an opportunity to further understand the CD40–CD40L signalling pathway in human immune responses.
Literature
1.
go back to reference El Fakhry Y, Alturaihi H, Diallo D, Merhi Y, Mourad W. Critical role of lipid rafts in CD154-mediated T cell signaling. Eur J Immunol. 2010;40:770–9.PubMedCrossRef El Fakhry Y, Alturaihi H, Diallo D, Merhi Y, Mourad W. Critical role of lipid rafts in CD154-mediated T cell signaling. Eur J Immunol. 2010;40:770–9.PubMedCrossRef
2.
go back to reference Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102:565–75.PubMedCrossRef Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102:565–75.PubMedCrossRef
3.
go back to reference Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373–84.CrossRef Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373–84.CrossRef
4.
go back to reference Tsuge I, Matsuoka H, Nakagawa A, Kamachi Y, Aso K, Negoro T, et al. Necrotizing toxoplasmic encephalitis in a child with the X-linked hyper-IgM syndrome. Eur J Pediatr. 1998;157:735–7.PubMedCrossRef Tsuge I, Matsuoka H, Nakagawa A, Kamachi Y, Aso K, Negoro T, et al. Necrotizing toxoplasmic encephalitis in a child with the X-linked hyper-IgM syndrome. Eur J Pediatr. 1998;157:735–7.PubMedCrossRef
5.
go back to reference Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131:47–54.PubMedCrossRef Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131:47–54.PubMedCrossRef
6.
go back to reference Yong PF, Post FA, Gilmour KC, Grosse-Kreul D, King A, Easterbrook P, et al. Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand gene. J Clin Pathol. 2008;61:1220–2.PubMedCrossRef Yong PF, Post FA, Gilmour KC, Grosse-Kreul D, King A, Easterbrook P, et al. Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand gene. J Clin Pathol. 2008;61:1220–2.PubMedCrossRef
7.
go back to reference Gilmour KC, Walshe D, Heath S, Monaghan G, Loughlin S, Lester T, et al. Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM. Mol Pathol. 2003;56:256–62.PubMedCrossRef Gilmour KC, Walshe D, Heath S, Monaghan G, Loughlin S, Lester T, et al. Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM. Mol Pathol. 2003;56:256–62.PubMedCrossRef
8.
go back to reference Blaeser F, Kelly M, Siegrist K, Storch GA, Buller RS, Whitlock J, et al. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Clin Immunol. 2005;117:231–7.PubMedCrossRef Blaeser F, Kelly M, Siegrist K, Storch GA, Buller RS, Whitlock J, et al. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Clin Immunol. 2005;117:231–7.PubMedCrossRef
9.
go back to reference Seyama K, Kobayashi R, Hasle H, Apter AJ, Rutledge JC, Rosen D, et al. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis. 1998;178:318–24.PubMed Seyama K, Kobayashi R, Hasle H, Apter AJ, Rutledge JC, Rosen D, et al. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis. 1998;178:318–24.PubMed
10.
go back to reference Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92:2421–34.PubMed Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92:2421–34.PubMed
11.
12.
go back to reference Peitsch MC, Jongeneel CV. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int Immunol. 1993;5:233–8.PubMedCrossRef Peitsch MC, Jongeneel CV. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int Immunol. 1993;5:233–8.PubMedCrossRef
13.
go back to reference Thusberg J, Vihinen M. The structural basis of hyper IgM deficiency—CD40L mutations. Protein Eng Des Sel. 2007;20:133–41.PubMedCrossRef Thusberg J, Vihinen M. The structural basis of hyper IgM deficiency—CD40L mutations. Protein Eng Des Sel. 2007;20:133–41.PubMedCrossRef
14.
go back to reference van Essen D, Kikutani H, Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature. 1995;378:620–3.PubMedCrossRef van Essen D, Kikutani H, Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature. 1995;378:620–3.PubMedCrossRef
15.
go back to reference Gray D, Bergthorsdottir S, van Essen D, Wykes M, Poudrier J, Siepmann K. Observations on memory B-cell development. Semin Immunol. 1997;9:249–54.PubMedCrossRef Gray D, Bergthorsdottir S, van Essen D, Wykes M, Poudrier J, Siepmann K. Observations on memory B-cell development. Semin Immunol. 1997;9:249–54.PubMedCrossRef
16.
go back to reference Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1994;1:167–78.PubMedCrossRef Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1994;1:167–78.PubMedCrossRef
17.
go back to reference Gray D, Dullforce P, Jainandunsing S. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40–CD40 ligand interaction. J Exp Med. 1994;180:141–55.PubMedCrossRef Gray D, Dullforce P, Jainandunsing S. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40–CD40 ligand interaction. J Exp Med. 1994;180:141–55.PubMedCrossRef
18.
go back to reference Hollenbaugh D, Wu LH, Ochs HD, Nonoyama S, Grosmaire LS, Ledbetter JA, et al. The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1. Journal of Clinical Investigation. 1994;94:616–22.PubMedCrossRef Hollenbaugh D, Wu LH, Ochs HD, Nonoyama S, Grosmaire LS, Ledbetter JA, et al. The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1. Journal of Clinical Investigation. 1994;94:616–22.PubMedCrossRef
19.
go back to reference de Saint Basile G, Tabone MD, Durandy A, Phan F, Fischer A, Le Deist F. CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization. Eur J Immunol. 1999;29:367–73.PubMedCrossRef de Saint Basile G, Tabone MD, Durandy A, Phan F, Fischer A, Le Deist F. CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization. Eur J Immunol. 1999;29:367–73.PubMedCrossRef
Metadata
Title
Phenotypic Heterogeneity in a Family with a CD40 Ligand Intracellular Domain Mutation
Authors
S. Kiani-Alikhan
P. F. K. Yong
K. C. Gilmour
D. Grosse-Kreul
E. G. Davies
M. A. A. Ibrahim
Publication date
01-02-2012
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2012
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9607-6

Other articles of this Issue 1/2012

Journal of Clinical Immunology 1/2012 Go to the issue